Genetics

This scientific blog post examines a 2025 Mendelian randomization study investigating how inflammatory proteins and metabolic pathways may contribute to multiple sclerosis risk. The study identifies interleukin-7 (IL-7) as a potential causal inflammatory factor and suggests that part of its effect may be mediated through circulating metabolites involved in bile acid metabolism, the kynurenine pathway, sphingolipid biology, albumin regulation, and amino acid–phosphate balance. By integrating large-scale genetic data with mediation analysis, the research provides a systems-level perspective on the interaction between immune signaling and metabolism in MS, while also highlighting important limitations and directions for future therapeutic and biomarker research.